Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis

References

• Kaptoge S, Pennells L, De Bacquer D, et al. World health organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7(10):e1332–e45.
   PubMed Web of Science ®Google Scholar
• Schober A, Nazari-Jahantigh M, Weber C. MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis. Nat Rev Cardiol. 2015;12(6):361–374.
   PubMed Web of Science ®Google Scholar
• Mussbacher M, Salzmann M, Brostjan C, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis. Front Immunol. 2019;10:85.
   PubMed Web of Science ®Google Scholar
• Tabas I, García-Cardeña G, Owens GK. Recent insights into the cellular biology of atherosclerosis. J Cell Biol. 2015;209(1):13–22.
   PubMed Web of Science ®Google Scholar
• Stancu CS, Toma L, Sima AV. Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. Cell Tissue Res. 2012;349(2):433–446.
   PubMed Web of Science ®Google Scholar
• Sitia S, Tomasoni L, Atzeni F, et al. From endothelial dysfunction to atherosclerosis. Autoimmun Rev. 2010;9(12):830–834.
   PubMed Web of Science ®Google Scholar
• Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115(10):1285–1295.
   PubMed Web of Science ®Google Scholar
• Vita JA, Keaney JF. Jr Endothelial function: a barometer for cardiovascular risk? Am Heart Assoc. 2002;106:640–642.
   Google Scholar
• Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascul Pharmacol. 2016;84:1–7.
   PubMed Web of Science ®Google Scholar
• Quintavalle M, Condorelli G, Elia L. Arterial remodeling and atherosclerosis: miRNAs involvement. Vascul Pharmacol. 2011;55(4):106–110.
   PubMed Web of Science ®Google Scholar
• Shokri Y, Variji A, Nosrati M, et al. Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: genotypic and phenotypic evaluation. Diabetes Res Clin Pract. 2020;161:108067.
   PubMed Web of Science ®Google Scholar
• Harada-Shiba M, Kinoshita M, Kamido H, et al. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem. 1998;273(16):9681–9687.
   PubMed Web of Science ®Google Scholar
• Gao S, Liu J. Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. Chronic Dis Transl Med. 2017;3(2):89–94.
   PubMedGoogle Scholar
• Lara-Guzmán OJ, Gil-Izquierdo Á, Medina S, et al. Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages. Redox Biol. 2018;15:1–11.
   PubMed Web of Science ®Google Scholar
• Sima AV, Stancu CS, Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res. 2009;335(1):191–203.
   PubMed Web of Science ®Google Scholar
• Madrigal-Matute J, Rotllan N, Aranda JF, et al. MicroRNAs and atherosclerosis. Curr Atheroscler Rep. 2013;15(5):322.
   PubMed Web of Science ®Google Scholar
• Nazari-Jahantigh M, Egea V, Schober A, et al. MicroRNA-specific regulatory mechanisms in atherosclerosis. J Mol Cell Cardiol. 2015;89(Pt A):35–41.
   PubMedGoogle Scholar
• Mahrooz A, Mackness M, Bagheri A, et al. The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: the missing link between environmental and genetic regulation. Clin Biochem. 2019;73:1–10.
   PubMed Web of Science ®Google Scholar
• Price NL, Ramírez CM, Fernández-Hernando C. Relevance of microRNA in metabolic diseases. Crit Rev Clin Lab Sci. 2014;51(6):305–320.
   PubMed Web of Science ®Google Scholar
• Aranda JF, Madrigal-Matute J, Rotllan N, et al. MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. Free Radic Biol Med. 2013;64:31–39.
   PubMed Web of Science ®Google Scholar
• Mahrooz A, Mackness M. Epigenetics of paraoxonases. Curr Opin Lipidol. 2020;31(4):200–205.
   PubMed Web of Science ®Google Scholar
• Diener C, Galata V, Keller A, et al. MicroRNA profiling from dried blood samples. Crit Rev Clin Lab Sci. 2019;56(2):111–117.
   PubMed Web of Science ®Google Scholar
• Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol. 2013;9(9):513–521.
   PubMed Web of Science ®Google Scholar
• Natarelli L, Geißler C, Csaba G, et al. miR-103 promotes endothelial maladaptation by targeting lncWDR59. Nat Commun. 2018;9(1):2645–2645.
   PubMedGoogle Scholar
• Xu X, Ma C, Liu C, et al. Knockdown of long noncoding RNA XIST alleviates oxidative low-density lipoprotein-mediated endothelial cells injury through modulation of miR-320/NOD2 axis. Biochem Biophys Res Commun. 2018;503(2):586–592.
   PubMed Web of Science ®Google Scholar
• Lu G, Tian P, Zhu Y, et al. LncRNA XIST knockdown ameliorates oxidative low-density lipoprotein-induced endothelial cells injury by targeting miR-204-5p/TLR4. J Biosci. 2020;45(1):1–12.
   PubMed Web of Science ®Google Scholar
• Zhang R, Qin Y, Zhu G, et al. Low serum miR-320b expression as a novel indicator of carotid atherosclerosis. J Clin Neurosci. 2016;33:252–258.
   PubMed Web of Science ®Google Scholar
• Huang S, Lu W, Ge DI, et al. A new microRNA signal pathway regulated by long noncoding RNA TGFB2-OT1 in autophagy and inflammation of vascular endothelial cells. Autophagy. 2015;11(12):2172–2183.
   PubMed Web of Science ®Google Scholar
• Chen C, Cheng G, Yang X, et al. Tanshinol suppresses endothelial cells apoptosis in mice with atherosclerosis via lncRNA TUG1 up-regulating the expression of miR-26a. Am J Transl Res. 2016;8(7):2981–2991.
   PubMed Web of Science ®Google Scholar
• Wu X, Zheng X, Cheng J, et al. LncRNA TUG1 regulates proliferation and apoptosis by regulating miR-148b/IGF2 axis in ox-LDL-stimulated VSMC and HUVEC. Life Sci. 2020;243:117287.
   PubMed Web of Science ®Google Scholar
• Zhang X, Shi H, Wang Y, et al. Down-regulation of hsa-miR-148b inhibits vascular smooth muscle cells proliferation and migration by directly targeting HSP90 in atherosclerosis. Am J Transl Res. 2017;9(2):629–637.
   PubMed Web of Science ®Google Scholar
• Ye J, Wang C, Wang D, et al. LncRBA GSA5, up-regulated by ox-LDL, aggravates inflammatory response and MMP expression in THP-1 macrophages by acting like a sponge for miR-221. Exp Cell Res. 2018;369(2):348–355.
   PubMed Web of Science ®Google Scholar
• Tao Z, Cao Z, Wang X, et al. Long noncoding RNA SNHG14 regulates ox-LDL-induced atherosclerosis cell proliferation and apoptosis by targeting miR-186-5p/WIPF2 axis. Hum Exp Toxicol. 2021;40(1):47–59.
   PubMed Web of Science ®Google Scholar
• Sun B, Cao Q, Meng M, et al. MicroRNA-186-5p serves as a diagnostic biomarker in atherosclerosis and regulates vascular smooth muscle cell proliferation and migration. Cell Mol Biol Lett. 2020;25:27–29.
   PubMed Web of Science ®Google Scholar
• Lu Y, Xi J, Zhang Y, et al. SNHG1 inhibits ox-LDL-induced inflammatory response and apoptosis of HUVECs via up-Regulating GNAI2 and PCBP1. Front Pharmacol. 2020;11:703.
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zhang G, Liang X, et al. LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis. Mol Cell Biochem. 2021;476(1):443–455.
   PubMed Web of Science ®Google Scholar
• Dai Y, Wu X, Dai D, et al. MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1. Redox Biol. 2018;16:255–262.
   PubMed Web of Science ®Google Scholar
• Hua Z, Ma K, Liu S, et al. LncRNA ZEB1-AS1 facilitates ox-LDL-induced damage of HCtAEC cells and the oxidative stress and inflammatory events of THP-1 cells via miR-942/HMGB1 signaling. Life Sci. 2020;247:117334.
   PubMed Web of Science ®Google Scholar
• Yang J-X, Pan Y-Y, Ge J-H, et al. Tanshinone II a attenuates TNF-α-induced expression of VCAM-1 and ICAM-1 in endothelial progenitor cells by blocking activation of NF-κB. Cell Physiol Biochem. 2016;40(1–2):195–206.
   PubMedGoogle Scholar
• Papayianni A, Alexopoulos E, Giamalis P, et al. Circulating levels of ICAM‐1, VCAM‐1, and MCP‐1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant. 2002;17(3):435–441.
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhang Z, Cao Y, et al. MiR-590-5p inhibits oxidized- LDL induced angiogenesis by targeting LOX-1. Sci Rep. 2016;6(1):22607–22609.
   PubMedGoogle Scholar
• Zhang Y-H, He K, Shi G. Effects of microRNA-499 on the inflammatory damage of endothelial cells during coronary artery disease via the targeting of PDCD4 through the NF-Κβ/TNF-α signaling pathway. Cell Physiol Biochem. 2017;44(1):110–124.
   PubMedGoogle Scholar
• Wang W, Li T, Gao L, et al. Plasma miR-208b and miR-499: potential biomarkers for severity of coronary artery disease. Dis Markers. 2019;2019:1–7.
   Web of Science ®Google Scholar
• Yuan X, Chen J, Dai M. Paeonol promotes microRNA-126 expression to inhibit monocyte adhesion to ox-LDL-injured vascular endothelial cells and block the activation of the PI3K/Akt/NF-κB pathway. Int J Mol Med. 2016;38(6):1871–1878.
   PubMed Web of Science ®Google Scholar
• Fu C, Yin D, Nie H, et al. Notoginsenoside R1 protects HUVEC against oxidized low density lipoprotein (Ox-LDL)-induced atherogenic response via down-regulating miR-132. Cell Physiol Biochem. 2018;51(4):1739–1750.
   PubMedGoogle Scholar
• Li H, Zhang P, Li F, et al. Plasma miR-22-5p, miR-132-5p, and miR-150-3p are associated with acute myocardial infarction. Biomed Res Int. 2019;2019:5012648.
   PubMed Web of Science ®Google Scholar
• Daher J, Martin M, Rousseau A, et al. Myeloperoxidase oxidized LDL interferes with endothelial cell motility through miR-22 and heme oxygenase 1 induction: possible involvement in reendothelialization of vascular injuries. Mediators Inflamm. 2014;2014:134635.
   PubMed Web of Science ®Google Scholar
• Chen B, Luo L, Zhu W, et al. miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: an observational study. Medicine. 2016;95(33):e4418.
   PubMed Web of Science ®Google Scholar
• Ogura S, Kakino A, Sato Y, et al. Lox-1: the multifunctional receptor underlying cardiovascular dysfunction. Circ J. 2009;73(11):93–99.
   Web of Science ®Google Scholar
• Qin B, Xiao B, Jiang T, et al. Effects of miR-590-5p on ox-LDL-induced endothelial cells apoptosis and LOX-1 expression. Zhong nan da xue xue bao Yi xue ban=. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37(7):675–681.
   PubMedGoogle Scholar
• Chen Z, Wang M, He Q, et al. MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1. Exp Ther Med. 2017;13(5):1702–1710.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu J, Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation. 2011;124(2):175–184.
   PubMed Web of Science ®Google Scholar
• Kin K, Miyagawa S, Fukushima S, et al. Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc. 2012;1(5):e000745.
   PubMed Web of Science ®Google Scholar
• Chen K-C, Hsieh I-C, Hsi E, et al. Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1. J Cell Sci. 2011;124(Pt 23):4115–4124.
   PubMed Web of Science ®Google Scholar
• Bao M-h, Zhang Y-W, Lou X-y, et al. Protective effects of let-7a and let-7b on oxidized low-density lipoprotein induced endothelial cell injuries. PLoS One. 2014;9(9):e106540.
   PubMed Web of Science ®Google Scholar
• Guri Y, Hall MN. mTOR signaling confers resistance to targeted cancer drugs. Trends Cancer. 2016;2(11):688–697.
   PubMed Web of Science ®Google Scholar
• Tamaddoni A, Mohammadi E, Sedaghat F, et al. The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. Pharmacol Res. 2020;156:104798.
   PubMed Web of Science ®Google Scholar
• Gu Y, Becker V, Zhao Y, et al. miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (SMO) and bone morphogenetic protein (BMP)-2. Faseb J. 2019;33(6):7213–7224.
   PubMed Web of Science ®Google Scholar
• Liu H, Yang N, Fei Z, et al. Analysis of plasma miR-208a and miR-370 expression levels for early diagnosis of coronary artery disease. Biomed Rep. 2016;5(3):332–336.
   PubMed Web of Science ®Google Scholar
• Tian D, Sha Y, Lu JM, et al. MiR-370 inhibits vascular inflammation and oxidative stress triggered by oxidized low-density lipoprotein through targeting TLR4. J Cell Biochem. 2018;119(7):6231–6237.
   PubMed Web of Science ®Google Scholar
• Qin B, Shu Y, Long L, et al. MicroRNA-142-3p induces atherosclerosis-associated endothelial cell apoptosis by directly targeting rictor. Cell Physiol Biochem. 2018;47(4):1589–1603.
   PubMedGoogle Scholar
• Tang F, Yang T-L. MicroRNA-126 alleviates endothelial cells injury in atherosclerosis by restoring autophagic flux via inhibiting of PI3K/Akt/mTOR pathway. Biochem Biophys Res Commun. 2018;495(1):1482–1489.
   PubMed Web of Science ®Google Scholar
• Che J, Liang B, Zhang Y, et al. Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of autophagy via inhibiting PI3K/Akt/mTOR pathway in human endothelial cells. Cardiovasc Pathol. 2017;31:57–62.
   PubMed Web of Science ®Google Scholar
• Cui S, Tang J, Wang S, et al. Kaempferol protects lipopolysaccharide-induced inflammatory injury in human aortic endothelial cells (HAECs) by regulation of miR-203. Biomed Pharmacother. 2019;115:108888.
   PubMed Web of Science ®Google Scholar
• Faccini J, Ruidavets J-B, Cordelier P, et al. Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease. Sci Rep. 2017;7(1):42916–42910.
   PubMedGoogle Scholar
• Nazari-Jahantigh M, Wei Y, Noels H, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012;122(11):4190–4202.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Pan X, Yang S, et al. miR-155 promotes ox-LDL-induced autophagy in human umbilical vein endothelial cells. Mediators Inflamm. 2017;2017:9174801.
   PubMed Web of Science ®Google Scholar
• Lv J, Yang L, Guo R, et al. Ox-LDL-induced microRNA-155 promotes autophagy in human endothelial cells via repressing the Rheb/ mTOR Pathway. Cell Physiol Biochem. 2017;43(4):1436–1448.
   PubMedGoogle Scholar
• Yin S, Yang S, Pan X, et al. MicroRNA‐155 promotes ox‐LDL‐induced autophagy in human umbilical vein endothelial cells by targeting the PI3K/Akt/mTOR pathway. Mol Med Rep. 2018;18(3):2798–2806.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yan W, Lu X, et al. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. Eur J Cell Biol. 2011;90(8):642–648.
   PubMed Web of Science ®Google Scholar
• Yu S, Wong SL, Lau CW, et al. Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/akt/eNOS pathway in human coronary artery endothelial cells. Biochem Biophys Res Commun. 2011;407(1):44–48.
   PubMed Web of Science ®Google Scholar
• Ou H-C, Lee W-J, Lee S-D, et al. Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol. 2010;248(2):134–143.
   PubMed Web of Science ®Google Scholar
• Pan Q, Liao X, Liu H, et al. MicroRNA-125a-5p alleviates the deleterious effects of ox-LDL on multiple functions of human brain microvessel endothelial cells. Am J Physiol Cell Physiol. 2017;312(2):C119–C130.
   PubMed Web of Science ®Google Scholar
• Li JB, Wang HY, Yao Y, et al. Overexpression of microRNA-138 alleviates human coronary artery endothelial cell injury and inflammatory response by inhibiting the PI3K/Akt/eNOS pathway. J Cell Mol Med. 2017;21(8):1482–1491.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jiao T, Fu W, et al. miR-410-3p regulates proliferation and apoptosis of fibroblast-like synoviocytes by targeting YY1 in rheumatoid arthritis. Biomed Pharmacother. 2019;119:109426.
   PubMed Web of Science ®Google Scholar
• Liu N-N, Dong Z-L, Han L-L. MicroRNA-410 inhibition of the TIMP2-dependent MAPK pathway confers neuroprotection against oxidative stress-induced apoptosis after ischemic stroke in mice. Brain Res Bull. 2018;143:45–57.
   PubMed Web of Science ®Google Scholar
• Hu M-Y, Du X-B, Hu H-B, et al. MiR-410 inhibition induces HUVECs proliferation and represses ox-LDL-triggered apoptosis through activating STAT3. Biomed Pharmacother. 2018;101:585–590.
   PubMed Web of Science ®Google Scholar
• Lu Z, Wang F, Yu P, et al. Inhibition of miR-29b suppresses MAPK signaling pathway through targeting SPRY1 in atherosclerosis. Vascul Pharmacol. 2018;102:29–36.
   PubMed Web of Science ®Google Scholar
• Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2007;4(8):444–454.
   PubMedGoogle Scholar
• Zhong X, Zhang L, Li Y, et al. Kaempferol alleviates ox-LDL-induced apoptosis by up-regulation of miR-26a-5p via inhibiting TLR4/NF-κB pathway in human endothelial cells. Biomed Pharmacother. 2018;108:1783–1789.
   PubMed Web of Science ®Google Scholar
• Zhang X, Cai H, Zhu M, et al. Circulating microRNAs as biomarkers for severe coronary artery disease. Medicine. 2020;99(17):e19971.
   PubMed Web of Science ®Google Scholar
• Boldin MP, Taganov KD, Rao DS, et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med. 2011;208(6):1189–1201.
   PubMed Web of Science ®Google Scholar
• Petrkova J, Borucka J, Kalab M, et al. Increased expression of miR-146a in valvular tissue from patients with aortic valve stenosis. Front Cardiovasc Med. 2019;6:86.
   PubMed Web of Science ®Google Scholar
• Yang K, He YS, Wang XQ, et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett. 2011;585(6):854–860.
   PubMed Web of Science ®Google Scholar
• Cheng HS, Sivachandran N, Lau A, et al. MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med. 2013;5(7):1017–1034.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang S, Zhao W, et al. Oxidized low-density lipoprotein upregulates microRNA-146a via JNK and NF-κB signaling. Mol Med Rep. 2016;13(2):1709–1716.
   PubMed Web of Science ®Google Scholar
• Wei Q, Tu Y, Zuo L, et al. MiR-345-3p attenuates apoptosis and inflammation caused by oxidized low-density lipoprotein by targeting TRAF6 via TAK1/p38/NF-kB signaling in endothelial cells. Life Sci. 2020;241:117142.
   PubMed Web of Science ®Google Scholar
• Chen M, Li W, Zhang Y, et al. MicroRNA-20a protects human aortic endothelial cells from Ox-LDL-induced inflammation through targeting TLR4 and TXNIP signaling. Biomed Pharmacother. 2018;103:191–197.
   PubMed Web of Science ®Google Scholar
• Qin B, Xiao B, Liang D, et al. MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and bcl-2 expression. Biochem Biophys Res Commun. 2011;410(1):127–133.
   PubMed Web of Science ®Google Scholar
• Li H-W, Meng Y, Xie Q, et al. miR-98 protects endothelial cells against hypoxia/reoxygenation induced-apoptosis by targeting caspase-3. Biochem Biophys Res Commun. 2015;467(3):595–601.
   PubMed Web of Science ®Google Scholar
• Wu R, Tang S, Wang M, et al. MicroRNA-497 induces apoptosis and suppresses proliferation via the bcl-2/bax-caspase9-caspase3 pathway and cyclin D2 protein in HUVECs. PLoS One. 2016;11(12):e0167052.
   PubMed Web of Science ®Google Scholar
• Zhao J, Ou S-L, Wang W-Y, et al. MicroRNA-1907 enhances atherosclerosis-associated endothelial cell apoptosis by suppressing Bcl-2. Am J Transl Res. 2017;9(7):3433–3442.
   PubMed Web of Science ®Google Scholar
• Zhong X, Li P, Li J, et al. Downregulation of microRNA‐34a inhibits oxidized low‐density lipoprotein‐induced apoptosis and oxidative stress in human umbilical vein endothelial cells. Int J Mol Med. 2018;42(2):1134–1144.
   PubMed Web of Science ®Google Scholar
• Su G, Sun G, Liu H, et al. Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2. Heart Vessels. 2018;33(10):1185–1194.
   PubMed Web of Science ®Google Scholar
• Han H, Qu G, Han C, et al. MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort. Exp Mol Med. 2015;47(2):e138.
   PubMedGoogle Scholar
• Wang Y, Xie Y, Zhang A, et al. Exosomes: an emerging factor in atherosclerosis. Biomed Pharmacother. 2019;115:108951.
   PubMed Web of Science ®Google Scholar
• Chen L, Hu L, Li Q, et al. Exosome-encapsulated miR-505 from ox-LDL-treated vascular endothelial cells aggravates atherosclerosis by inducing NET formation. Acta Biochim Biophys Sin. 2019;51(12):1233–1241.
   Google Scholar
• Yao Y, Sun W, Sun Q, et al. Platelet-derived exosomal MicroRNA-25-3p inhibits coronary vascular endothelial cell inflammation through Adam10 via the NF-κB signaling pathway in ApoE–/– Mice. Front Immunol. 2019;10:2205.
   PubMed Web of Science ®Google Scholar
• Chen D, Wang K, Zheng Y, et al. Exosomes-Mediated LncRNA ZEB1-AS1 facilitates cell injuries by miR-590-5p/ETS1 axis through the TGF-β/smad pathway in oxidized low-density lipoprotein-induced human umbilical vein endothelial cells. J Cardiovasc Pharmacol. 2021;77(4):480–490.
   PubMed Web of Science ®Google Scholar
• Huang R, Hu Z, Cao Y, et al. MiR-652-3p inhibition enhances endothelial repair and reduces atherosclerosis by promoting cyclin D2 expression. EBioMedicine. 2019;40:685–694.
   PubMed Web of Science ®Google Scholar
• Moya IM, Halder G. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol. 2019;20(4):211–226.
   PubMed Web of Science ®Google Scholar
• He J, Bao Q, Yan M, et al. The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease. Br J Pharmacol. 2018;175(8):1354–1361.
   PubMed Web of Science ®Google Scholar
• Wang K-C, Yeh Y-T, Nguyen P, et al. Flow-dependent Yap/TAZ activities regulate endothelial phenotypes and atherosclerosis. Proc Natl Acad Sci USA. 2016;113(41):11525–11530.
   PubMed Web of Science ®Google Scholar
• Hu J, Liu T, Zhang Z, et al. Oxidized low-density lipoprotein promotes vascular endothelial cell dysfunction by stimulating miR-496 expression and inhibiting the Hippo pathway effector YAP. Cell Biol Int. 2019;43(5):528–538.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zheng J, Lin J, et al. miR-758 mediates oxLDL-dependent vascular endothelial cell damage by suppressing the succinate receptor SUCNR1. Gene. 2018;663:1–8.
   PubMed Web of Science ®Google Scholar
• Mandolini C, Santovito D, Marcantonio P, et al. Identification of microRNAs 758 and 33b as potential modulators of ABCA1 expression in human atherosclerotic plaques. Nutr Metab Cardiovasc Dis. 2015;25(2):202–209.
   PubMed Web of Science ®Google Scholar
• Wu CY, Zhou ZF, Wang B, et al. MicroRNA‐328 ameliorates oxidized low‐density lipoprotein‐induced endothelial cells injury through targeting HMGB1 in atherosclerosis. J Cell Biochem. 2019;120(2):1643–1650.
   Web of Science ®Google Scholar
• Qiao Y, Wang C, Kou J, et al. MicroRNA-23a suppresses the apoptosis of inflammatory macrophages and foam cells in atherogenesis by targeting HSP90. Gene. 2020;729:144319.
   PubMed Web of Science ®Google Scholar
• Ruan W, Xu J-M, Li S-B, et al. Effects of down-regulation of microRNA-23a on TNF-α-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc Res. 2012;93(4):623–632.
   PubMed Web of Science ®Google Scholar
• Zhang J-J, Liu W-Q, Peng J-J, et al. miR-21-5p/203a-3p promote ox-LDL-induced endothelial cell senescence through down-regulation of mitochondrial fission protein Drp1. Mech Ageing Dev. 2017;164:8–19.
   PubMed Web of Science ®Google Scholar
• Yang X, Li D, Qi YZ, et al. MicroRNA-217 ameliorates inflammatory damage of endothelial cells induced by oxidized LDL by targeting EGR1. Mol Cell Biochem. 2020;475(1–2):41–51.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Z, Li W, et al. MicroRNA-217-5p ameliorates endothelial cell apoptosis induced by ox-LDL by targeting CLIC4. Nutr Metab Cardiovasc Dis. 2020;30(3):523–533.
   PubMed Web of Science ®Google Scholar
• de Yébenes VG, Briones AM, Martos-Folgado I, et al. Aging-associated miR-217 aggravates atherosclerosis and promotes cardiovascular dysfunction. Arterioscler Thromb Vasc Biol. 2020;40(10):2408–2424.
   PubMed Web of Science ®Google Scholar
• Geng Z, Xu F, Zhang Y. MiR-129-5p-mediated beclin-1 suppression inhibits endothelial cell autophagy in atherosclerosis. Am J Transl Res. 2016;8(4):1886–1894.
   PubMed Web of Science ®Google Scholar
• Li C, Yang L, Wu H, et al. Paeonol inhibits oxidized low-density lipoprotein-induced vascular endothelial cells autophagy by upregulating the expression of miRNA-30a. Front Pharmacol. 2018;9:95.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang WN, Xu SB, et al. Micro RNA‐214‐3p: a link between autophagy and endothelial cell dysfunction in atherosclerosis. Acta Physiologica. 2018;222(3):e12973.
   Web of Science ®Google Scholar
• Li P, Zhong X, Li J, et al. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis. Biochem Biophys Res Commun. 2018;503(4):2833–2840.
   PubMed Web of Science ®Google Scholar
• Wang X, Li X, Wu Y, et al. Upregulation of miR-223 abrogates NLRP3 inflammasome-mediated pyroptosis to attenuate oxidized low-density lipoprotein (ox-LDL)-induced cell death in human vascular endothelial cells (ECs). In Vitro Cell Dev Biol Anim. 2020;56(8):670–679.
   PubMed Web of Science ®Google Scholar
• Loyer X, Potteaux S, Vion A-C, et al. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res. 2014;114(3):434–443.
   PubMed Web of Science ®Google Scholar
• Chen F, Ye X, Jiang H, et al. MicroRNA-151 attenuates apoptosis of endothelial cells induced by oxidized low-density lipoprotein by targeting interleukin-17A (IL-17A). J Cardiovasc Transl Res. 2021;14(3):400–408.
   PubMed Web of Science ®Google Scholar
• Hu Y, Xu R, He Y, et al. Downregulation of microRNA‐106a‐5p alleviates ox‐LDL‐mediated endothelial cell injury by targeting STAT3. Mol Med Rep. 2020;22(2):783–791.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang N, Dong B, et al. MicroRNA-122 promotes endothelial cell apoptosis by targeting XIAP: therapeutic implication for atherosclerosis. Life Sci. 2019;232:116590.
   PubMed Web of Science ®Google Scholar
• Wang J, Li P, Xu X, et al. MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-Mediated methylation of STAT3. Front Immunol. 2020;11:907.
   PubMed Web of Science ®Google Scholar